CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 11 enrolled
Drug / intervention
Interviewother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03231020
NCT03231020N/ACompleted

Parental Experience in the Single Ventricle Interstage Utilizing a mHealth Innovation: A Comparative Case Study

Children's Mercy Hospital Kansas City·observational·Posted Jul 27, 2017·Updated Jul 31, 2020

In Brief

An observational study evaluating Interview for mHealth and Adherence, Patient. Completed, enrolled 11 participants across 1 site.

Detailed Summary

The purpose of this study is to provide a rich description of the parental perspectives of utilizing a mHealth application for data transfer during the single ventricle interstage monitoring period. A gap in the body of knowledge of single ventricle cardiac disease interstage will be explored with these research questions: 1) How do parents of children (\< 5 years of age) with single ventricle disease describe their experiences using a mHealth application during the interstage period (first 6-12 months of child's life)? And 2) How do these experiences influence their decision making for use of the mHealth application?

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJul 27, 2017
Enrollment StartSep 13, 2019
Primary CompletionApr 26, 2020
Study CompletionMay 30, 2020
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 8.9 years ago

Interventions

Interviewother

The proposed research study uses a comparative case study methodology, utilizing multiple sources of data to deeply examine 8-10 "cases," each of which is defined as parent(s) of a child (\< 5 years of age) with single ventricle disease who used the mHealth application. One group of cases (4-5) will have used the mHealth application less than recommended (non-adherent to the home monitoring recommendations) or declined to use the application and returned it before the end of the interstage period. The other group of comparison cases (4-5 cases) will have used the application as recommended by the clinical team (adherent) and continued doing so through the interstage period.